CRTh2 mAbs (Amgen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCRTh2 mAbs (Amgen)
Drug Alias NameCRTh2 mAbs (Sosei/Abgenix)prostaglandin D2 antagonist mAbs (Sosei/Amgen)prostaglandin D2 antagonist mAbs (Sosei/Abgenix)SOA-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProstaglandin D2 receptor 2 antagonistsProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomeraseProstaglandin D2 receptor 2
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncAbgenix IncorporatedNxera Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A